{"id":"https://openalex.org/W2129684203","doi":null,"title":"Life-threatening toxicity in a dihydropyrimidine dehydrogenase-deficient patient after treatment with topical 5-fluorouracil.","display_name":"Life-threatening toxicity in a dihydropyrimidine dehydrogenase-deficient patient after treatment with topical 5-fluorouracil.","publication_year":1999,"publication_date":"1999-08-01","ids":{"openalex":"https://openalex.org/W2129684203","mag":"2129684203","pmid":"https://pubmed.ncbi.nlm.nih.gov/10473079"},"language":"en","primary_location":{"id":"pmid:10473079","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10473079","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Case Reports"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108778527","display_name":"Martin R. Johnson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M R Johnson","raw_affiliation_strings":["Department of Pharmacology and Toxicology and Comprehensive Cancer Center, University of Alabama at Birmingham, 35294, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology and Comprehensive Cancer Center, University of Alabama at Birmingham, 35294, USA","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111841927","display_name":"Alexander Hageboutros","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102322142","display_name":"Rutgers, The State University of New Jersey","ror":"https://ror.org/05vt9qd57","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A Hageboutros","raw_affiliation_strings":["Rutgers, The State University of New Jersey [New Brunswick]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rutgers, The State University of New Jersey [New Brunswick]","institution_ids":["https://openalex.org/I102322142"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046171285","display_name":"Kangsheng Wang","orcid":"https://orcid.org/0009-0009-8392-4148","observed_orcids":["https://orcid.org/0009-0009-8392-4148","https://orcid.org/0009-0003-4443-1259"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K Wang","raw_affiliation_strings":["University of Alabama at, Birmingham"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at, Birmingham","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061328403","display_name":"L. B. High","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L High","raw_affiliation_strings":["University of Alabama at, Birmingham"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at, Birmingham","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109905487","display_name":"Jeffrey Bingham Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J B Smith","raw_affiliation_strings":["University of Alabama at, Birmingham"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at, Birmingham","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064038800","display_name":"Robert B. Diasio","orcid":"https://orcid.org/0000-0002-9648-9570","observed_orcids":["https://orcid.org/0000-0002-9648-9570"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R B Diasio","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.3201,"has_fulltext":false,"cited_by_count":224,"citation_normalized_percentile":{"value":0.96818071,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"5","issue":"8","first_page":"2006","last_page":"11"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9653000235557556,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9653000235557556,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.020600000396370888,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dihydropyrimidine-dehydrogenase-deficiency","display_name":"dihydropyrimidine dehydrogenase deficiency","score":0.9919999837875366},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.9330000281333923},{"id":"https://openalex.org/keywords/topical-chemotherapy","display_name":"topical chemotherapy","score":0.7609999775886536},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.8389999866485596},{"id":"https://openalex.org/keywords/pyrimidine-catabolism","display_name":"pyrimidine catabolism","score":0.7590000033378601},{"id":"https://openalex.org/keywords/splicing-mutation","display_name":"splicing mutation","score":0.5989999771118164},{"id":"https://openalex.org/keywords/ubiquitination","display_name":"ubiquitination","score":0.7179999947547913},{"id":"https://openalex.org/keywords/ubiquitin-proteasome-degradation","display_name":"ubiquitin-proteasome degradation","score":0.9010000228881836},{"id":"https://openalex.org/keywords/pharmacogenetics","display_name":"pharmacogenetics","score":0.5889999866485596},{"id":"https://openalex.org/keywords/cancer-patients","display_name":"cancer patients","score":0.3269999921321869}],"concepts":[{"id":"https://openalex.org/C2778050828","wikidata":"https://www.wikidata.org/wiki/Q1114455","display_name":"Dihydropyrimidine dehydrogenase","level":5,"score":0.9808242321014404},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.6151257753372192},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.6128833889961243},{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.6115767955780029},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.46660396456718445},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42825794219970703},{"id":"https://openalex.org/C2779491297","wikidata":"https://www.wikidata.org/wiki/Q3338704","display_name":"Neurotoxicity","level":3,"score":0.42186883091926575},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3975585103034973},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3634546995162964},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3518226444721222},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3149358630180359},{"id":"https://openalex.org/C123321153","wikidata":"https://www.wikidata.org/wiki/Q22676802","display_name":"Thymidylate synthase","level":4,"score":0.28971168398857117}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D002280","descriptor_name":"Basal Cell Carcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003967","descriptor_name":"Diarrhea","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D004252","descriptor_name":"DNA Mutational Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D006471","descriptor_name":"Gastrointestinal Hemorrhage","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007963","descriptor_name":"Leukocytes, Mononuclear","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010088","descriptor_name":"Oxidoreductases","qualifier_ui":"Q000172","qualifier_name":"deficiency","is_major_topic":true},{"descriptor_ui":"D010088","descriptor_name":"Oxidoreductases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014498","descriptor_name":"Uracil","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014498","descriptor_name":"Uracil","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D015153","descriptor_name":"Blotting, Western","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015212","descriptor_name":"Inflammatory Bowel Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D016133","descriptor_name":"Polymerase Chain Reaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017384","descriptor_name":"Sequence Deletion","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D042943","descriptor_name":"Dihydrouracil Dehydrogenase (NADP)","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:10473079","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10473079","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Case Reports"},{"id":"mag:2129684203","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10473079","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[{"id":"https://openalex.org/G6183759621","display_name":"Genetic Polymorphism of Dihydropyrimidine Dehydrogenase","funder_award_id":"R01CA062164","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1507760891","https://openalex.org/W1511975037","https://openalex.org/W1525050249","https://openalex.org/W1584377347","https://openalex.org/W1645370161","https://openalex.org/W1991343218","https://openalex.org/W1994540349","https://openalex.org/W2027950584","https://openalex.org/W2044318138","https://openalex.org/W2056310324","https://openalex.org/W2068502996","https://openalex.org/W2077258384","https://openalex.org/W2100021150","https://openalex.org/W2103109018","https://openalex.org/W2110984592","https://openalex.org/W2125561839","https://openalex.org/W2128635872","https://openalex.org/W2149984280","https://openalex.org/W2178970217","https://openalex.org/W2467811085","https://openalex.org/W4405992764"],"related_works":["https://openalex.org/W2172119759","https://openalex.org/W2056901624","https://openalex.org/W7096460996","https://openalex.org/W2100322741","https://openalex.org/W2134094359","https://openalex.org/W2903394941","https://openalex.org/W2341830230","https://openalex.org/W2066333148","https://openalex.org/W1902640206","https://openalex.org/W2116815399"],"abstract_inverted_index":{"In":[0],"humans,":[1],"80-90%":[2],"of":[3,7,96,143,163,188],"an":[4],"administered":[5],"dose":[6],"5-fluorouracil":[8],"(5-FU)":[9],"is":[10,128,136],"degraded":[11],"by":[12,178],"dihydropyrimidine":[13],"dehydrogenase":[14],"(DPD;":[15],"EC":[16],"1.3.1.2),":[17],"the":[18,52,90,124,141,160,179,186,189],"initial":[19],"rate-limiting":[20],"enzyme":[21],"in":[22,45,89,100,108,159,185],"pyrimidine":[23],"catabolism.":[24],"Cancer":[25],"patients":[26],"with":[27,63,148,168],"decreased":[28],"DPD":[29,73,111,126,133,190],"activity":[30],"are":[31],"at":[32],"increased":[33],"risk":[34],"for":[35],"severe":[36],"toxicity":[37,165],"including":[38],"diarrhea,":[39],"stomatitis,":[40],"mucositis,":[41],"myelosuppression,":[42],"neurotoxicity,":[43],"and,":[44],"some":[46],"cases,":[47],"death.":[48],"We":[49,138],"now":[50],"report":[51],"first":[53],"known":[54],"cancer":[55],"patient":[56],"who":[57],"developed":[58],"life-threatening":[59,164],"complications":[60],"after":[61,166],"treatment":[62,167],"topical":[64,149,170],"5-FU":[65,150],"and":[66,76,114],"was":[67],"shown":[68],"subsequently":[69],"to":[70,82,86,105,121],"have":[71],"profound":[72],"deficiency.":[74],"RT-PCR":[75],"genomic":[77],"PCR":[78],"methodologies":[79],"were":[80,118],"used":[81,120],"identify":[83],"a":[84,101,131,154,169,183],"G":[85],"A":[87],"mutation":[88],"GT":[91],"5'":[92],"splicing":[93],"recognition":[94],"sequence":[95],"intron":[97],"14,":[98],"resulting":[99],"165-bp":[102],"deletion":[103],"(corresponding":[104],"exon":[106],"14)":[107],"this":[109,144],"patient's":[110],"mRNA.":[112],"Immunoprecipitation":[113],"Western":[115],"blot":[116],"analysis":[117],"then":[119],"demonstrate":[122],"that":[123,135,140,176],"aberrant":[125],"mRNA":[127],"translated":[129],"into":[130],"nonfunctional":[132],"protein":[134],"ubiquitinated.":[137],"conclude":[139],"presence":[142],"metabolic":[145],"defect":[146],"combined":[147],"(a":[151],"drug":[152],"demonstrating":[153],"narrow":[155],"therapeutic":[156],"index)":[157],"results":[158],"unusual":[161],"presentation":[162],"drug.":[171],"These":[172],"data":[173],"further":[174],"suggest":[175],"degradation":[177],"ubiquitin-proteosome-mediated":[180],"system":[181],"plays":[182],"role":[184],"elimination":[187],"protein.":[191]},"counts_by_year":[{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}